The maker of a potent opioid medication has brought on a heavy hitter in the pharmaceutical industry to lead its legal department during a tumultuous time.
Insys Therapeutics Inc. named Mark Nance chief legal officer and general counsel. He also will serve as a member of the Phoenix-based company’s senior management team, according to a statement announcing his appointment.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]